Home - GeoVax, Inc.
GeoVax’s development pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine (GEO-CM04S1) and therapy for advanced head and neck cancer …
About Us - GeoVax, Inc.
GeoVax Labs, Inc. is a clinical-stage biotechnology company developing vaccines and immunotherapies against infectious diseases and cancers using novel proprietary platforms.
Blog - GeoVax, Inc.
GeoVax Announces Upcoming Presentation at the European Hematology Association 2025 Congress Highlighting Positive Immune Response Data for GEO-CM04S1 in CLL Patients
Pipeline - GeoVax, Inc.
Aids Vaccine Research - GeoVax, Inc.Invert colors Dark contrast Light contrast Low saturation High saturation Highlight links Highlight headings Screen reader Read mode Content scaling …
Investors - GeoVax, Inc.
Quality – Ensuring that we conduct our business, in all manners, following the principle of ”Right-First-Time”, defines how we approach our jobs, shareholder and stakeholder relationships and …
GeoVax Accelerates Development of GEO-MVA Vaccine Amid …
Jul 29, 2025 · GeoVax has a strong IP portfolio in support of its technologies and product candidates, holding worldwide rights for its technologies and products. For more information …
GeoVax Receives Formal EMA Scientific Advice Supporting Pivotal …
Dec 18, 2025 · GeoVax has a strong IP portfolio in support of its technologies and product candidates, holding worldwide rights for its technologies and products. For more information …
GeoVax Highlights Growing Urgency for Diversified Mpox Vaccine …
Jul 16, 2025 · GeoVax is now accelerating engagement with global and regional health authorities as Mpox re-emerges with more virulent and transmissible strains in vulnerable populations.
GeoVax Provides Update on BARDA Project NextGen and Outlines …
Apr 16, 2025 · GeoVax is advancing continuous cell line manufacturing for MVA-based vaccines, offering a path to scalable, cost-effective production—including localized manufacturing for low …
GeoVax Receives Favorable European Regulatory Guidance …
Jun 16, 2025 · GeoVax has a strong IP portfolio in support of its technologies and product candidates, holding worldwide rights for its technologies and products. For more information …